David M. Goldenberg receives Society of Nuclear Medicine's 2005 Paul C. Aeber...( TORONTO Canada--David M. Goldenberg S...)

TORONTO, Canada--David M. Goldenberg, Sc.D., M.D., founder and president of the Garden State Cancer Center and the Center for Molecular Medicine and Immunology in Belleville, N.J., received the 2005 Paul C. Aebersold Award for outstanding achievement in basic science applied to nuclear medicine at the 52nd Annual Meeting of the Society of Nuclear Medicine June 19 in Toronto, Canada.

Goldenberg pioneered the development of radiolabeled antibodies for various applications in the detection, diagnosis and therapy of cancer. Under his leadership, the scientists and clinicians at the Garden State Cancer Center have developed antibodies for the diagnosis, detection and treatment of solid tumors such as colorectal, pancreatic, lung, breast and ovarian cancers, as well as certain hematologic cancers such as lymphoma and multiple myeloma. He has overseen the in-house clinic as well as clinical outreach at affiliated institutions in the United States and Europe for treatment of cancer patients with radiolabeled antibodies. He also helped develop two diagnostic radiopharmaceuticals marketed by Immunomedics Inc., which he established in 1982.

Goldenberg, who has been in his current position at the Garden State Cancer Center since 1990, is also the president and chief executive officer of CMMI, a not-for-profit, independent, specialized research center he formed in 1982; the center focuses on the development of biological strategies to detect and treat cancer and immunological diseases. Over the past 30 years, this distinguished scientist has been a major contributor to the current knowledge of the basic principles of the preparation and utilization of radioimmunoconjugates in medical diagnosis, including functional imaging and guided radionuclide therapy. Goldenberg, who has published more than 500 articles in peer-reviewed journals, is currently exploring the use of positron emission tomography (PET) tracers in immunodiagnosis and therapy, especially by pretarge
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-708-9000
Society of Nuclear Medicine
19-Jun-2005

Page: 1 2 3
Related biology news :

1. Carnegie Mellons David Sholl identifies new materials
2. McGovern Institute Scolnick Prize awarded to David Julius
3. David H. Baker to be honored for work in animal and nutritional science
4. Stevens Davidson Laboratory acquires new research vessel
5. Dan David Prize awarded to two leading American cancer researchers
6. Tufts David Walt named Howard Hughes Medical Institute Professor
7. SNM member David James Brooks receives 2005 Kuhl-Lassen Award for research in brain imaging
8. Scripps Nierenberg Prize awarded to nature filmmaker Sir David Attenborough
9. NNii media advisory about David Kirbys book questioning vaccine safety
10. Carnegie Mellons Peter Adams receives EPA research grant
11. Philadelphia ecologist receives top Mongolia honor